Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide Plus Lactulose vs Lactulose for Overt Hepatic Encephalopathy
NCT02464124Phase 3Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in hepatic encephalopathy (HE). Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02464124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464124.